RxDoctor Payments Data

Rhonda Heath, APRN

Psychiatric/Mental Health · Pompano Beach, FLNPI 1306314984

Payments from drug & device makers

$1,196in general payments, 2019–2025

Across 55 payments — averaging $21.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$294
  • Alkermes, Inc.$162
  • Otsuka America Pharmaceutical, Inc.$157
  • Takeda Pharmaceuticals U.S.A., Inc.$117
  • Teva Pharmaceuticals USA, Inc.$99
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$73
  • plus $295 from 8 others

What the payments were for

  • Food & beverage$1,196100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,196 in reported general payments places this provider in the 60th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$21,361
Medicare patients
33
Services billed
242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole12$35,569
BelsomraSuvorexant71$30,606
Lurasidone Hcl11$7,754
TrintellixVortioxetine Hydrobromide14$7,240
VyvanseLisdexamfetamine Dimesylate11$4,700
Aripiprazole43$3,657
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl11$2,477
Duloxetine Hcl94$1,928
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine23$1,771
Mirtazapine109$1,649
Ziprasidone Hcl16$1,436
Venlafaxine Hcl ErVenlafaxine Hcl121$1,223
Clonazepam134$1,150
Trazodone Hcl211$1,052
Quetiapine Fumarate79$1,016

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$157$35,56912 claims
MerckBelsomra$18$30,60671 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$117$11,94025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Pompano Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →